Newsroom | 5719 results

Sorted by: Latest

Health Insurance
-

QIAGEN unterstützt Forschungs- und Überwachungsmaßnahmen zum Ausbruch des Bundibugyo-Ebolavirus

VENLO, Niederlande, und GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Verfügbarkeit von zwei maßgeschneiderten digitalen PCR-Assays für Forschungszwecke (Research Use Only, RUO) bekannt gegeben. Diese sollen Forschungs- und Überwachungsmaßnahmen im Zusammenhang mit dem Ausbruch des Bundibugyo-Ebolavirus unterstützen. Die Assays wurden für den Einsatz mit dem digitalen PCR-System QIAcuity entwickelt und sollen qualifizierten Laboren dabei...
-

QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak

VENLO, Netherlands, & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the availability of two custom-designed research-use-only (RUO) digital PCR assays to support infectious disease research and surveillance efforts related to the Bundibugyo ebolavirus outbreak. The assays are designed for use with the QIAcuity digital PCR system and are intended to help qualified laboratories evaluate emerging pathogen targets in research, wastewater s...
-

ICHRA Masters Expands into Florida to Meet Growing Broker Demand for ICHRA Support

ORLANDO, Fla.--(BUSINESS WIRE)--ICHRA Masters is proud to announce the opening of its Florida office, expanding its presence to meet growing broker demand for ICHRA support as employers increasingly explore alternatives to traditional group health plans. The new office, located at 1800 Pembrook Drive, Suite 300, ORLANDO, FL 32810, will serve as a regional hub for brokers working with Individual Health Reimbursement Arrangements (ICHRAs). ICHRA Masters works with brokers nationwide to support th...
-

AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Palmetto GBA has issued a final Local Coverage Determination (LCD L40205) establishing Medicare coverage guidance for irreversible electroporation (IRE), the non-thermal ablation technology delivered by the Company's NanoKnife System, in...
-

Live Well San Diego Honors Dr. Stefan Willging with 2026 Public Health Champion Award

BETHESDA, Md.--(BUSINESS WIRE)--Stefan Willging, MD, of Hillcrest Internal Medicine was recently honored at the 2026 Live Well San Diego 25th Public Health Champion awards ceremony....
-

Newron Pharmaceuticals to Participate in June Investor Conferences

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS), today announced that Stefan Weber, CEO and Roberto Galli, CFO, will participate in the following investor conferences in June: Jefferies Global Healthcare Conference, June 2–4, 2026, New York H.C. Wainwright 7th Annual Neuro Perspectives...
-

Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings, Inc. (Nasdaq: HIND)(“Vyome”), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today reports financial results for the first quarter ended March 31, 2026, and provides a corporate update. Krishna Gupta, Chairman of Vyome, said, “Over the last several quarters, Vyome has executed with focus and discipline, advancing differentiated programs in areas of significant unmet medical need focused on...
-

Secretome Therapeutics Announces $30 Million Series A Financing From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy

PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced the closing of a $30 million Series A financing from RA Capital Management, LP (“RA Capital”), a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital was the sole investor in the financing. The Serie...
-

Paralign Health Raises $3 Million Seed Round to Build National EMS-Led Preventative Care Network in Rural America

KANSAS CITY, Mo.--(BUSINESS WIRE)--Paralign Health, the healthcare technology company enabling health plans to reach underserved patients through Mobile Integrated Health-Community Paramedicine (MIH-CP), announced it has raised $3 million in seed funding to grow its national network of fire departments and EMS agencies, accelerate the development of its technology platform, and expand its health plan partnerships. The round was led by Flyover Capital, with participation from SixThirty Ventures,...
-

Northwell Health’s annual walk raises record $1.32M+ to improve health in local communities

WANTAGH, N.Y.--(BUSINESS WIRE)--More than 5,000 people came together across six locations for the Northwell Walk to Raise Health, raising more than $1.32 million for local hospital programs and services. Supporters including patients and their families, community members and Northwell employees joined walks on Sunday, May 17 in New York at Jones Beach and in Port Jefferson, Riverhead, Westchester and Staten Island — and for the first time — in Norwalk, Connecticut, to welcome the newest members...